Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas.
about
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practiceEmerging molecular classifications and therapeutic implications for gastric cancerHER2 testing in gastric cancer: An updateHER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the StomachTrastuzumab in the management of gastroesophageal cancer: patient selection and perspectivesActivation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer.High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia-Pacific task forceAssociation between HSP90 and Her2 in gastric and gastroesophageal carcinomas.HER2 in solid tumors: more than 10 years under the microscope; where are we now?HER2 discordance between paired primary gastric cancer and metastasis: a meta-analysis.Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual-color in situ hybridization.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study.HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis.Aberrant loss of dickkopf-3 in gastric cancer: can it predict lymph node metastasis preoperatively?Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer.HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks.HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.HER2 Status in Gastric Cancer: Comparison between Primary and Distant Metastatic Disease.HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study.Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
P2860
Q26741253-65EB372E-6BAA-421D-84EB-3AA6B6698FABQ26745525-2DBE426A-2CD3-4B0A-96AC-82167F2A6CBCQ26746253-8D2B1B85-E154-4693-8FE5-AE02418D5576Q26780318-AC588980-5139-43E1-90D1-967D9F0D0B58Q28077666-26B019F4-7D1D-422B-9784-9624E145BFEFQ33670896-D2D8FDB0-77FA-4668-9114-0B08F427703DQ33733858-542A0D92-05CB-434B-AFE2-E6BBAE2AA562Q34456612-DF82D87A-2419-483F-9C2F-7D2A9A5A8874Q34559419-93E5A91F-6BB8-4E84-B460-C9DAE7572DD3Q34852929-B200EC54-FFD2-4B0A-9584-E79514A64341Q35211263-79D513D5-8D4F-4D3B-96E5-291B00A6A8F2Q35538755-028C15FA-908F-484F-836E-235E915782E3Q35719104-2B0AAC49-10A8-413E-9D1A-A93851234565Q36546068-B7F97550-ED7D-4372-968E-01F3FC660270Q36801203-3E034AB9-ED52-4555-8886-C5A5D6608AF5Q37736423-6F460BA9-B5AA-4571-B654-0D1F1725FF5CQ39069439-8981BE79-12FA-4D35-986F-B44233C6B48CQ39080349-68820658-59CF-4968-A766-DFD3C1CF4541Q39183864-268C90F0-8BCD-4D2E-8D13-02EC9D09B900Q39363485-07FA1998-0FCC-4580-9ECC-AFAF08D5CC95Q41554939-A9CE8D56-9E8E-4781-8395-C53A672B9BEAQ47096927-73D7CCB5-8641-42D0-BFA1-C95EA5025A87Q48132295-98652207-DA54-4338-B5C6-DF8F79742275Q50993984-1AA17CCE-B2BC-40F4-8F46-C8BF0FEED615Q51671698-56186896-4338-4B87-8CA3-255768FD19FAQ53010792-02DD8139-E7AB-4B2F-9608-0299C7C89F4FQ54269864-47907AFF-E324-4429-90B8-FEE4CA9F510FQ55066506-CAA610B8-A2F7-4DA3-A9C4-1EF925E23767Q55071600-9E4A4718-3097-4758-B0CD-0E686EC5B638Q57109545-ED66AD89-B0E9-481A-9CCB-2BEF65F07183
P2860
Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Heterogeneity of ERBB2 in gast ...... ary and metastatic carcinomas.
@en
Heterogeneity of ERBB2 in gast ...... ary and metastatic carcinomas.
@nl
type
label
Heterogeneity of ERBB2 in gast ...... ary and metastatic carcinomas.
@en
Heterogeneity of ERBB2 in gast ...... ary and metastatic carcinomas.
@nl
prefLabel
Heterogeneity of ERBB2 in gast ...... ary and metastatic carcinomas.
@en
Heterogeneity of ERBB2 in gast ...... ary and metastatic carcinomas.
@nl
P2093
P2860
P1433
P1476
Heterogeneity of ERBB2 in gast ...... ary and metastatic carcinomas.
@en
P2093
Eun Yoon Cho
Jeeyun Lee
Junhun Cho
Kyeongmee Park
Kyoung-Mee Kim
Seonwoo Kim
Tae Sung Sohn
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.205
P577
2012-12-14T00:00:00Z